Check out Pro
Top Companies
Recent Trades
Cluster Buys
Sectors
Blog
Join the Insiderviz Pro waitlist
Actinium Pharmaceuticals, Inc. (ATNM)
All trades on this company by insiders. Hover over bubbles for specific trade details. Drag along the graph for custom price change. Green - Buy, Red - Sell, Orange - Congress Member.
Healthcare
Biotechnology
DATE
INSIDER
COMPANY
OWNED SHARES
SHARES TRADED
PRICE
NET TOTAL
BUY
10 Dec 2018
O'Loughlin Steve
Principal Financial Officer, Officer
Actinium Pharmaceuticals, Inc.
(ATNM)
35,500
+0%
333.333
$13.05
$4,350.00
BUY
10 Dec 2018
SETH SANDESH
Chairman & CEO, Director, Officer
Actinium Pharmaceuticals, Inc.
(ATNM)
153,333
+0%
333.333
$13.12
$4,372.00
BUY
19 Nov 2018
Ludwig Dale L.
Chief Scientific Officer, Officer
Actinium Pharmaceuticals, Inc.
(ATNM)
10,000
+3%
333.333
$13.50
$4,499.00
BUY
13 Jul 2018
SETH SANDESH
CEO, Director, Officer
Actinium Pharmaceuticals, Inc.
(ATNM)
143,333
+0%
333.333
$23.70
$7,900.00
BUY
15 Jun 2018
O'Loughlin Steve
Principal Financial Officer, Officer
Actinium Pharmaceuticals, Inc.
(ATNM)
25,500
+1%
400
$15.00
$6,000.00
BUY
19 Apr 2018
SETH SANDESH
Chairman & CEO, Director, Officer
Actinium Pharmaceuticals, Inc.
(ATNM)
133,333
+0%
166.667
$11.40
$1,900.00
BUY
28 Feb 2018
Shetty Ajit
Director
Actinium Pharmaceuticals, Inc.
(ATNM)
22,730
+3%
757.667
$12.90
$9,773.90
BUY
2 Aug 2017
Ray Nitya G.
Executive Vice President, Officer
Actinium Pharmaceuticals, Inc.
(ATNM)
10,000
+3%
333.333
$22.50
$7,500.00
BUY
2 Aug 2017
SETH SANDESH
Chairman & CEO, Director, Officer
Actinium Pharmaceuticals, Inc.
(ATNM)
75,833
+1%
1,111.1
$22.50
$24,999.75
BUY
15 Jun 2017
O'Loughlin Steve
Principal Financial Officer, Officer
Actinium Pharmaceuticals, Inc.
(ATNM)
3,500
+3%
116.667
$35.10
$4,095.00
BUY
15 Jun 2017
SETH SANDESH
Chairman and CEO, Director, Officer
Actinium Pharmaceuticals, Inc.
(ATNM)
37,500
+0%
250
$34.90
$8,725.00
BUY
15 Jun 2017
Berger Mark Stanley
Chief Medical Officer, Officer
Actinium Pharmaceuticals, Inc.
(ATNM)
5,000
+3%
166.667
$33.30
$5,550.00
BUY
30 Dec 2016
SETH SANDESH
Executive Chairman, Director, Officer
Actinium Pharmaceuticals, Inc.
(ATNM)
35,000
+0%
166.667
$26.40
$4,400.00
BUY
12 Dec 2016
SETH SANDESH
Executive Chairman, Director, Officer
Actinium Pharmaceuticals, Inc.
(ATNM)
30,000
+0%
166.667
$29.40
$4,900.00
SELL
30 Aug 2016
Memorial Sloan-Kettering Cancer Center
10% Owner
Actinium Pharmaceuticals, Inc.
(ATNM)
4,821,226
-0%
6,430.9
$54.79
$352,372.40
SELL
26 Aug 2016
Memorial Sloan-Kettering Cancer Center
10% Owner
Actinium Pharmaceuticals, Inc.
(ATNM)
4,914,988
-0%
1,666.667
$51.30
$85,495.02
SELL
15 Aug 2016
Memorial Sloan-Kettering Cancer Center
10% Owner
Actinium Pharmaceuticals, Inc.
(ATNM)
4,952,888
-0%
315.6
$51.61
$16,286.96
SELL
12 Jul 2016
Memorial Sloan-Kettering Cancer Center
10% Owner
Actinium Pharmaceuticals, Inc.
(ATNM)
4,962,056
-0%
103.333
$54.01
$5,581.00
SELL
8 Jul 2016
Memorial Sloan-Kettering Cancer Center
10% Owner
Actinium Pharmaceuticals, Inc.
(ATNM)
4,965,056
-0%
733
$54.00
$39,582.00
SELL
5 Jul 2016
Memorial Sloan-Kettering Cancer Center
10% Owner
Actinium Pharmaceuticals, Inc.
(ATNM)
4,987,046
-0%
694.667
$54.36
$37,762.20
SELL
30 Jun 2016
Memorial Sloan-Kettering Cancer Center
10% Owner
Actinium Pharmaceuticals, Inc.
(ATNM)
5,091,995
-0%
4,936.667
$54.38
$268,435.94
SELL
15 Jun 2016
Memorial Sloan-Kettering Cancer Center
10% Owner
Actinium Pharmaceuticals, Inc.
(ATNM)
5,155,986
-0%
1,120.633
$57.00
$63,876.10
SELL
2 Jun 2016
Memorial Sloan-Kettering Cancer Center
10% Owner
Actinium Pharmaceuticals, Inc.
(ATNM)
5,196,395
-0%
593
$60.23
$35,715.80
SELL
31 May 2016
Memorial Sloan-Kettering Cancer Center
10% Owner
Actinium Pharmaceuticals, Inc.
(ATNM)
5,242,709
-0%
5,648.334
$59.02
$333,384.53
SELL
26 May 2016
Memorial Sloan-Kettering Cancer Center
10% Owner
Actinium Pharmaceuticals, Inc.
(ATNM)
5,389,745
-0%
1,335.6
$57.70
$77,060.56
SELL
25 May 2016
Memorial Sloan-Kettering Cancer Center
10% Owner
Actinium Pharmaceuticals, Inc.
(ATNM)
5,427,313
-0%
1,213.333
$57.06
$69,235.50
SELL
22 Apr 2016
Memorial Sloan-Kettering Cancer Center
10% Owner
Actinium Pharmaceuticals, Inc.
(ATNM)
5,455,813
-0%
1,752.567
$61.20
$107,265.22
SELL
19 Apr 2016
Memorial Sloan-Kettering Cancer Center
10% Owner
Actinium Pharmaceuticals, Inc.
(ATNM)
5,509,590
-0%
6,549.9
$60.90
$398,919.40
BUY
16 Apr 2016
TRAVERSA SERGIO
Director
Actinium Pharmaceuticals, Inc.
(ATNM)
3,000
+3%
100
$60.60
$6,060.00
BUY
14 Apr 2016
Steinhart Richard I
Director
Actinium Pharmaceuticals, Inc.
(ATNM)
2,500
+3%
83.333
$60.30
$5,025.00
BUY
14 Apr 2016
Nicholson, C. David
Director
Actinium Pharmaceuticals, Inc.
(ATNM)
15,000
+1%
166.667
$60.00
$10,000.00
BUY
14 Apr 2016
SETH SANDESH
Director, Executive Chairman
Actinium Pharmaceuticals, Inc.
(ATNM)
23,500
+2%
500
$59.80
$29,900.00
BUY
14 Apr 2016
DAVE KAUSHIK J
CEO and Interim CFO, Director, Officer
Actinium Pharmaceuticals, Inc.
(ATNM)
86,500
+0%
333.333
$60.54
$20,180.00
Home